Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MEDI vs LYFIX overlap: 19% of top holdings shared

Bottom line

How much do MEDI and LYFIX overlap?

19% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 18.0% of MEDI's assets and 21.3% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

MEDILYFIX
Weight overlap (top 25)19%
Shared holdings6
Weight in shared holdings18.0%21.3%
Total positions4462
Expense ratio0.8%1.41%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings MEDI and LYFIX have in common

Holding% of MEDI% of LYFIXOverlap
Gilead Sciences Inc5.10%5.53%5.10%
Rhythm Pharmaceuticals Inc4.02%2.25%2.25%
AbbVie Inc3.09%1.95%1.95%
Insmed Inc2.52%2.60%2.52%
Argenx SE2.07%3.59%2.07%
Vertex Pharmaceuticals Inc1.22%5.33%1.22%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MEDI

  1. Eli Lilly & Co — 20.78%
  2. Ascendis Pharma A/S — 13.61%
  3. Intuitive Surgical Inc — 2.83%
  4. Cencora Inc — 2.75%
  5. Revolution Medicines Inc — 2.54%
  6. Merck & Co Inc — 2.47%
  7. Boston Scientific Corp — 2.40%
  8. Natera Inc — 2.26%
  9. Abivax SA — 2.16%
  10. Insulet Corp — 2.10%
  11. Vaxcyte Inc — 2.06%
  12. McKesson Corp — 2.02%
  13. Legend Biotech Corp — 1.91%
  14. Danaher Corp — 1.73%
  15. Guardant Health Inc — 1.54%

Only in LYFIX

  1. Astrazeneca Plc — 4.63%
  2. First American Funds Inc — 4.26%
  3. Roivant Sciences Ltd — 3.67%
  4. Neurocrine Biosciences Inc — 3.51%
  5. Incyte Corp — 3.51%
  6. Axsome Therapeutics Inc — 3.43%
  7. Apogee Therapeutics Inc — 3.28%
  8. Ionis Pharmaceuticals Inc — 2.62%
  9. Ascendis Pharma A/s — 2.62%
  10. Protagonist Therapeutics Inc — 2.41%
  11. Personalis Inc — 2.27%
  12. Jazz Pharmaceuticals Plc — 1.87%
  13. Amgen Inc — 1.83%
  14. Biogen Inc — 1.80%
  15. Catalyst Pharmaceuticals Inc — 1.59%

Asset mix

Asset typeMEDILYFIX
Stocks99.6%95.8%
Cash & short-term funds—4.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryMEDILYFIX
US76.7%76.0%
DK15.1%2.6%
NL2.6%4.7%
GB—4.6%
BM—3.7%
FR2.5%2.8%
IE—2.4%
KY1.9%1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do MEDI and LYFIX overlap?
About 19% by weight. 6 securities appear in both funds' top 25 holdings; they make up 18.0% of MEDI's assets and 21.3% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do MEDI and LYFIX have in common?
The largest shared holdings are Gilead Sciences Inc, Insmed Inc, Rhythm Pharmaceuticals Inc, Argenx SE, AbbVie Inc.
Should I own both MEDI and LYFIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, MEDI or LYFIX?
LYFIX is broader, with 62 positions versus 44 for MEDI. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.